TWO · 6712.TWO
Ever Supreme Bio Technology Co., Ltd
NT$150.50-NT$2.00 (-1.31%)
Ever Supreme Bio Technology Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 18.21% below the high.
Loading market information…
TWO · 6748.TWO · TWD
Stock price
Quote as of Oct 30, 2026, 06:59 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
ACRO Biomedical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 41.13% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
ACRO Biomedical Co., Ltd. is dedicated to the creation and manufacturing of biomaterial-based medical devices, specifically designed for applications in human tissue engineering and regenerative medicine. This company was established on June 26, 2014, and operates primarily from its headquarters in Kaohsiung, Taiwan.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:27 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$150.50-NT$2.00 (-1.31%)
Ever Supreme Bio Technology Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 18.21% below the high.
NT$177.00+NT$2.50 (+1.43%)
Steminent Biotherapeutics Inc.’s quoted price sits in the upper half of its reported 52-week range, 26.25% below the high.
NT$39.55-NT$0.50 (-1.25%)
Locus Cell Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 58.24% below the high.
NT$68.20-NT$0.40 (-0.58%)
UnicoCell Biomed Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.82% below the high.
NT$47.55+NT$4.30 (+9.94%)
SciVision Biotech Inc.’s quoted price sits in the lower half of its reported 52-week range, 48.15% below the high.
NT$35.10-NT$1.00 (-2.77%)
Maxigen Biotech Inc.’s quoted price sits in the lower half of its reported 52-week range, 27.33% below the high.
NT$26.40-NT$0.40 (-1.49%)
Taiwan Bio Therapeutics Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 19.76% below the high.
NT$58.00+NT$0.60 (+1.05%)
U-Neuron Biomedical Inc’s quoted price sits in the upper half of its reported 52-week range, 17.38% below the high.
